Pembrolizumab 400 mg every 6 weeks as firstline therapy for advanced melanoma KEYNOTE555 Results from cohort B of an openlabel phase 1 stud - G Cohen; B Rapoport; S Chan; Paul Ruff; A Arance; E et al (PUBLIC LIBRARY SCIENCE, 2025)